• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

EdRip supports Ipside's MBO

  • Alice Tchernookova
  • Alice Tchernookova
  • @alicetcherno
  • 09 September 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Edmond de Rothschild Investment Partners (EdRip), via its vehicle Cabestan Capital, has supported the MBO of patent rights specialist Ipside.

EdRip's investment in the group is thought to amount to less than €5m.
The founders of Ipside (previously known as Schmit-Chrétien) are fully exiting the company, while CEO Christophe Cornuéjols and members of the management team will take a majority stake.

The company is aiming to become one of the top five legal offices specialised in its field in France by 2020. Ipside will pursue its growth plan, hoping to develop its national activity by 50% and to develop its international activity via its China and US subsidiaries, which over the next five years are expected to generate around 15% of its revenues.

Ipside

  • DEAL:

    MBO

  • VALUE:

    <€5m

  • DEBT RATIO:

    3x EBITDA

  • LOCATION:

    Toulouse

  • SECTOR:

    Business support services

  • FOUNDED:

    1998

  • TURNOVER:

    €15.5m

  • EBITDA:

    €1m

  • STAFF:

    70

The deal marks the 18th investment made by EdRip's Cabestan Capital fund, a buyout vehicle closed in 2011 with €112m in commitments, of which 94% has now been invested.

The most recent investments made with the fund were Travelsoft in July – an MBO in which EdRip took over from MBO Partenaires and A Plus Finance – and Marietton in January, when the GP took part in a €12m funding round alongside Siparex and other backers.

Debt
BPI France, Banque Populaire and LCL jointly provided an A tranche of senior debt, representing a 3x EBITDA multiple. Ipside's EBITDA amounted to around €1m in 2015.

Company
Created in 1998, and based in Toulouse, Ipside advises clients on intellectual property rights, including author rights, patents and copyright. It is the result of a merger between the Ravina, Poupon and Schmit-Chrétien firms.

The group has 70 staff members, including 22 patent engineers and 13 legal professionals, spread across six offices in France and three in the US and China. It recorded a €15.5m turnover for 2015.

People
Edmond de Rothschild Investment Partners – André Renaison (investment director); Sabrina Bazire (senior associate). 

Advisers
Equity – Oderis Consulting, Julien Passerat, Norian Lebrot (financial due diligence); Advention Business Partners, Alban Neveux, Ivan Pavlocic (commercial due diligence); Ideact Avocats, Maud Partouche, Carole Hadrys (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • France
  • Support services
  • France
  • Andera Partners
  • BPI France

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013